Skip to Content
  1. All Products
  2. All Products
  3. Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody
-
Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody

https://www.kineret-eu.com/web/image/product.template/26273/image_1920?unique=58978df
(0 review)
Connects CD19 on B-cells to CD3 on T-cells, enabling T-cell–mediated cytotoxicity. A leading tool for leukemia and lymphoma research models.

1,234,567.00 € 1234567.0 EUR 1,234,567.00 € Tax Excluded

1,234,567.00 € Tax Excluded

Not Available For Sale

(0.00 € / Units)

    This combination does not exist.

    Contact Us

    Terms and Conditions
    30-day money-back guarantee
    Shipping: 2-3 Business Days

    Share

    Internal Reference: GMA-CD19
    Display Name: [GMA-CD19] Gentaur Blinatumomab – Anti-CD19 / CD3E Bispecific Antibody